Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Opened DDOG and FIX.
Closed DXPE for a 4% loss. It had been selling off since the start his morning. Some people may know something, I do not for sure and I hate to be the patsy at the table. Thank you Warren.
Some people just buy low and sell lower.👹
Bought back MCD Call and re sold it. Bought back COP 7 Calls.
Bought back DINO 5 Calls and opened ISRG and MU.
Opened PUBM.
Bought back Puts: ANET.
LMT Calls, COP Calls.
There are still 6% yielding tax advantaged preferred share available. Schwab, BAC to name a couple.
Opened JHG.
Added to OC.
Sold Calls: MCD, COP, O, CVS.
Opened NCLH at 15.77.
EXPLAINER-What are the FLiRT COVID variants and are they more contagious?
REUTERS 6:00 AM ET 5/24/2024
Symbol Last Price Change
PFE 28.69down 0 (0%)
MRNA 164.01down 0 (0%)
NVAX 15.15down 0 (0%)
QUOTES AS OF 04:10:00 PM ET 05/23/2024
By Michael Erman
NEW YORK, May 24 (Reuters) - The so-called FLiRT variants of SARS-CoV-2 coronavirus that cause COVID-19 have been the dominant forms of the virus circulating this year globally, according to the World Health Organization
The moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus' spike protein. One of them, called KP.2, has become the most commonly circulating variant in the United States over the past month, according to the U.S. Centers for Disease Control and Prevention.
Here is what you need to know about FLiRT.
HOW ARE THE FLIRT VARIANTS DIFFERENT FROM PREVIOUS VARIANTS? The FLiRT variants, which also include KP.2's "parental" lineage JN.1, have three key mutations on their spike protein that could help them evade antibodies, according to Johns Hopkins University.
ARE THE FLIRT VARIANTS MORE CONTAGIOUS OR LIKELY TO CAUSE MORE SEVERE ILLNESS?
Dr. Aaron Glatt, chief of infectious diseases at Mount Sinai South Nassau Hospital in Oceanside, New York, and a spokesperson for the Infectious Diseases Society of America said he has not seen evidence of an uptick in disease or hospitalizations, based on the data he tracks and experience with his own patients.
"There have been some significant changes in the variants, but I think in recent times it's not been as important, probably because of the immunity many, many people already have" from prior illness and vaccination.
CDC data suggests that COVID-related hospitalizations have trended downwards in recent weeks and the number of patients in emergency departments who have tested positive for COVID has been about flat for the past month.
Data suggests that COVID rates are also down year-over-year. The rate of COVID hospitalizations is less than half than a year earlier, and the amount of the antiviral Paxlovid currently being prescribed for COVID-19 is down around 60% from last year, according to analyst notes.
DO CURRENT VACCINES WORK AGAINST THE FLIRT VARIANTS?
The current vaccines should still have some benefit against the new variants, Glatt said. Since 2022, health regulators have asked vaccine makers to design new versions of the COVID-19 vaccines to better target circulating variants. Last month, Europe's regulator said vaccine makers should target the JN.1 variant. U.S. experts and regulators will meet to discuss vaccine design on June 5 after having postponed the meeting from May 16 in order to have more time to "obtain surveillance data and other information."
Makers of vaccines based on messenger RNA (mRNA) technology - Pfizer(PFE) with partner BioNTech, and Moderna(MRNA) - say they are waiting for the June 5 meeting before settling on the design of their next vaccines.
Novavax (NVAX), which makes a more traditional protein-based vaccine that takes longer to manufacture, has begun producing a shot targeting JN.1 consistent with recommendations from European regulators. (Reporting by Michael Erman; editing by Caroline Humer and Bill Berkrot)
The Bears are having that $5 special and then some at the Golden Arches.
A simple answer to an often asked question: Which way a market or stock go after closing a gap. Look at SPX chart. It gapped up this morning to a record high and then fast closed that gap and kept going down( in the direction of the closed gap).
Closed IBIT for a paltry 3% gain, if the market drops clower to a down 5-8% I can get it back a few dollars lower.
After 2.5 weeks bought back 30 Covered Calls in MTW for a 25%+ gain. Will resell it again on another day, when people like MTW.
One more scam we have to deal with, there are so many now. It just used to be the Nigerian scam via an email.
You are right, I see that in a few of them.
Opened HEI.
After selling 22 Puts in ELF at $4.99 per share, I bought them back today at $2.30 per share. Thank you approaching expiration date and great earnings.
I think the market is dealing with three large negates since yesterday.
1/Goldman said he is not expecting any rate cuts this year.
2/J. Dimon said a hard landing or stagflation is not out of the realm of possibility.
3/ Hawkish Feds were talking.
We could be in a 5% correction.
O's price dropped a bit so I bought back my 12 Covered Calls for a 28% gain over the sell price. I will resell them again when people are eager to buy them and the price rises. At that time the premium I get will be bigger.
Opened: SM, CRGY, CNRE, IVR and CAMT. Reloading some hot ones.
Good observations Elroy. I get junk email like that all day long. But sadly too many un educated believe in them.
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb
BENZINGA 2:43 PM ET 5/22/2024
Symbol Last Price Change
BNTX 101.935up +9.865 (+10.7147%)
NVAX 15.935down +1.025 (+6.8746%)
MRNA 163.41down +19.72 (+13.724%)
PFE 29.425down +0.865 (+3.0287%)
QUOTES AS OF 03:33:10 PM ET 05/22/2024
Shares of vaccine producers' stocks are trading higher Wednesday on reports indicating disease experts predict a small rise in COVID-19 cases this summer.
The Details:
According to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly dominant strain spreads. The new strain, KP.2, represents 28% of COVID-19 infections in the U.S. and experts believe its mutations have made the variant more immune evasive.
Much remains unknown about the KP.2 variant, however, research from Japan suggests current COVID-19 vaccines may be less effective against KP.2 than against previous variants.
The same research also suggests KP.2 might be less efficient at infecting cells, making the new variant more difficult to transmit and less likely to cause severe symptoms. Experts are predicting a rise in COVID-19 cases, however, they expect the rise to be smaller than in previous years.
Shares of vaccine-makers, including BioNTech SE(BNTX) and Novavax, Inc.(NVAX), are climbing as COVID-19 headlines return to the spotlight.
Moderna, Inc. (MRNA) shares are trading at new 52-week highs following the report, and Pfizer, Inc.(PFE) shares are also moving higher.
Related News: What’s Going On With Bitcoin Miner Iris Energy’s Stock?
BNTX, NVAX, MRNA, PFE Price Action: According to Benzinga Pro, BioNTech shares are up 8.58% at $99.97, Novavax(NVAX) shares are up 7.38% at $16.01, Moderna(MRNA) shares are up 10.2% at $158.29 and Pfizer(PFE) shares are up 2.45% at $29.26 at the time of publication Wednesday.
TXO was sold for a 20% gain the other two: GLDD and HOOD for a loss of 1%.
Obviously the momentum stopped for most of those sold this afternoon, even if not, I was not sure how deep a pull back we were in and where it would stop and reverse.
If mistaken I van always buy back the best of the best, if they were not losers in the trade.
Closed MHO and ALL.
Closed: PHM, ERO, AEYE, HIMS, RCMT and SKYW overall a net 5 % gain.
I wanted to Roll BTI, but with its dividend nearly 10% I did not want it to be called away.
My two homebuilders are getting hit on the bad home sales reports and it was followed by a negative rental rates report: PHM and MHO.
Closed HAL and added LXFR and HHS. Small caps will get a boost with the first rate cut, may have to wait until December for the cut.
An eye opener stats. The answer is humans can drive their cars, but should not eat food and Global Warming will be solved.😇
Seems like the market is waiting for the 800 pound gorilla to tell it where he wants to sit. NVDA reports tomorrow.
I was being cautious also.
Bought back 30 Puts in MO and 25 Calls in BMBL and JD 10 Calls.
I was in SCCO this morning, but learned of a big downgrade and the cost of opening another mine, so I changed my mind and exited with a little loss. It is the stalled Tia Maria Project. I am sure it will not be costless.
They will insure and will get re insurance from the likes of Lloyd's, etc.
However, only the wealthy will insure or can afford to insure. Here in FL home insurance is touching the clouds, especially if you are near the water. The price of waterfront land will be dropping as well as the homes on them. Land prices inland are rising.
Sold Puts: APP 5, ANET 1, ET 35.
Sold 2 Calls: GPS.
Opened SGHC.
Closed TNP, RYCEY, AFRM for little gains each.
Replaced them with SCCO, added to OC and almost doubled up on DEC.
I have ENB in several portfolios.
https://seekingalpha.com/symbol/ENB:CA?hasComeFromMpArticle=true
Sold MO 30 Puts with a strike price of 42.5.
Opened EMR.
Bought back ET puts and APP Puts.
Thank you Elroy.
I thought i saw an ad about a robot you can talk to and even have a conversation.
OT: Has anyone here tried Copilot with voice? Do you like it?